Edition:
United Kingdom

Regenxbio Inc (RGNX.OQ)

RGNX.OQ on NASDAQ Stock Exchange Global Select Market

31.75USD
8 Dec 2017
Change (% chg)

$1.45 (+4.79%)
Prev Close
$30.30
Open
$30.60
Day's High
$32.05
Day's Low
$30.60
Volume
86,490
Avg. Vol
87,018
52-wk High
$35.95
52-wk Low
$16.30

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Donald Hayden

61 2016 Independent Chairman of the Board

Kenneth Mills

42 2009 President, Chief Executive Officer, Executive Director

Vittal Vasista

49 2017 Chief Financial Officer

Patrick Christmas

46 2016 Senior Vice President, General Counsel

Curran Simpson

55 2015 Senior Vice President - Technical Operations